Viking Therapeutics (VKTX) Other Non-Current Assets (2014 - 2026)
Viking Therapeutics' Other Assets came in at $113,000 for Q3 2026, up 145.7% from $46,000 a year earlier but down 65.1% from the prior quarter.
Powered by 
Analysis
Viking Therapeutics (VKTX) Other Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Viking Therapeutics' Other Assets was $46,000, unchanged from FY2024.
- Other Assets carries a five-year compound annual growth rate of 9.7% (FY2020 to FY2025).
- Going back by year, Other Assets was $46,000 in FY2024 (+39.4%), $33,000 in FY2023 (unchanged), $33,000 in FY2022 (unchanged) and $33,000 in FY2021 (+13.8%).
- The five-year range for quarterly Other Assets is $33,000 (Q4 2021) to $324,000 (Q2 2026).
- Year-over-year, Other Assets increased in five of the last eight quarters, with growth averaging 105.0%.
- The fastest year-over-year change in Other Assets over five years came in Q2 2026 (growth of 604.3%), and the weakest in Q1 2026 (a decline of 28.3%).
- Business Quant data shows VKTX's Other Assets at $324,000 (Q2 2026), $33,000 (Q1 2026) and $46,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Viking Therapeutics | 3.65 Bn | 884.58 Mn | - | 315,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 315,000.00 |
| Jun 30, 2026 | 324,000.00 |
| Mar 31, 2026 | 33,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Mar 31, 2025 | 46,000.00 |
| Dec 31, 2024 | 46,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 33,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Dec 31, 2022 | 33,000.00 |
| Sep 30, 2022 | 33,000.00 |
| Jun 30, 2022 | 33,000.00 |
| Mar 31, 2022 | 33,000.00 |
| Dec 31, 2021 | 33,000.00 |
API Access
Viking Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();